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Abstract
Background: A number of intensive care (ICU) patients experience significant problems with physical, psychological,
and social functioning for some time after discharge from ICU. These problems have implications not just for patients,
but impose a continuing financial burden for the National Health Service. To support recovery, a number of hospitals
across the UK have developed Intensive Care follow-up clinics. However, there is a lack of evidence base to support
these, and this study aims to test the hypothesis that intensive care follow up programmes are effective and cost-effective
at improving physical and psychological quality of life in the year after intensive care discharge.
Methods/Design: This is a multi-centre, pragmatic, randomised controlled trial. Patients (n = 270) will be recruited
prior to hospital discharge from three intensive care units in the UK, and randomised to one of two groups. The control
group will receive standard in-hospital follow-up and the intervention group will participate in an ICU follow-up
programme with clinic appointments 2–3 and 9 months after ICU discharge.
The primary outcome measure is Health-related Quality of Life (HRQoL) 12 months after ICU discharge as measured
by the Short Form-36. Secondary measures include: HRQoL at six months; Quality-adjusted life years using EQ-5D;
posttraumatic psychopathology as measured by Davidson Trauma Scale; and anxiety and depression using the Hospital
Anxiety and Depression Scale at both six and twelve months after ICU discharge. Contacts with health services in the
twelve months after ICU discharge will be measured as part of the economic analysis.
Discussion: The provision of intensive care follow-up clinics within the UK has developed in an ad hoc manner, is
inconsistent in both the number of hospitals offering such a service or in the type of service offered. This study provides
the opportunity to evaluate such services both in terms of patient benefit and cost-effectiveness. The results of this study
therefore will inform clinical practice and policy with regard to the appropriate development of such services aimed at
improving outcomes after intensive care.
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Background
Over 100,000 patients are admitted to intensive care units
in the United Kingdom (UK) per year [1]. Of these over
40,000 are dead within one year of admission [2]. Over
the five years after an intensive care unit (ICU) admission
these patients also have an excess risk of death when com-
pared to an age and sex matched population [3]. Apart
from this excess mortality, it is now becoming clear that
intensive care patients continue to experience both physi-
cal (e.g. neuropathy, reduced mobility, and breathless-
ness) [4,5], and psychological problems (e.g. anxiety,
depression and posttraumatic stress) [6-9] for some time
after discharge from ICU. Approximately two thirds of
ICU survivors will experience significant problems with
physical and psychological health and social functioning,
and with 13% of patients experiencing severe limitations
in every day life [10,11]. Studies assessing Health-Related
Quality of Life (HRQoL) after intensive care suggest that
this improves over time [12,13], but is worse than before
admission to ICU [14,15], and worse than general popu-
lation norms [13,16,17]. Reported prevalence of anxiety
and depressive problems in this patient group ranges from
12% to 43% (for anxiety) [9,16], and 10% to 30% (for
depression) [9,16]. Reports also suggest that 14% to 27%
of intensive care patients may develop a posttraumatic
stress reaction [6,9] that may endure for a number of years
[7]. Patients' perceptions of the intensive care experience
itself are associated with subsequent distress, and patients'
subjective reports frequently include the presence of 'odd
perceptual experiences' [18], or 'nightmares' and 'halluci-
nations' [19] which seem real and distressing for them at
the time. The reported frequency of these experiences
ranges from 7% to 73% [20,21]. These continuing prob-
lems have implications not just for patients, but impose a
continuing financial burden for the National Health Serv-
ice (NHS) in terms of primary and secondary health care
costs.
Eighty hospitals across the UK have now developed Inten-
sive Care follow-up clinics in an attempt to improve out-
comes after ICU discharge [22]. This is despite a lack of an
evidence base for this intervention, although the Outreach
Forum of the Department of Health has issued guidelines
for the delivery of ICU follow-up services based on expert
opinion [11]. Despite these guidelines, it is clear that the
nature of these clinics varies between centres [22]. The
clinics aim to support recovery, are often multi-discipli-
nary in nature and offer patients the opportunity to dis-
cuss issues related to their intensive care experience over
two or three appointments in the year after ICU discharge
[22]. One of the other purported benefits of these clinics
is that ICU practitioners gain valuable information about
psychological and physical problems faced by patients
that can then be used to inform the management of future
patients [4,5]. The NHS is spending a large amount of
clinical resource on these clinics and this is likely to con-
tinue. Because there are only 80 ICU follow-up clinics in
the UK currently (30% of ICUs), with a large variety of
models and funding structures, there exists a window of
opportunity to evaluate this intervention before the intro-
duction of such clinics becomes more widespread.
Aims and objectives of the study
This study aims to test the hypothesis that intensive care
follow up programmes are effective and cost-effective at
improving physical and psychological quality of life in the
year after intensive care discharge. The study will investi-
gate also these outcomes in patient subgroups classified
according to illness severity, intensive care experience,
anxiety and depression and ICU length of stay. In addi-
tion, the study will establish the cost-effectiveness of such
clinics.
Methods/Design
This is a multi-centre, pragmatic, randomised controlled
trial. Patients will be randomised to one of two interven-
tion groups after ICU discharge but prior to discharge
from hospital.
Ethics Approval
Ethics approval was granted from the Fife and Forth Valley
Local Research Ethics Committee (Ethics Code: 06/
S0501/26).
Participants
Participants meeting the inclusion criteria will be
recruited from three intensive care units in the UK (2
teaching hospitals and 1 District General hospital).
Inclusion criteria
Patients receiving level three dependency care (ICU) at
any time during their hospital stay and who survive until
the time of hospital discharge [23]. There is no evidence
to guide which patients should be offered this service,
thus we have chosen to include all patients irrespective of
ICU length of stay.
Exclusion criteria
Patients will be excluded if they are: aged under 18 years;
not expected to survive to leave hospital; unable to com-
plete questionnaires; unable to attend clinics, or if they are
unable or unwilling to consent.
Outcome measures
Primary measures
HR-QOL 12 months after ICU discharge as measured by
the physical and mental component scores of the Short
Form-36 (SF-36) [24,25]. This is a comprehensive, generic
36-item questionnaire [26,27], well accepted by different
patient groups, is reliable [27,28], valid [26,29], showsBMC Health Services Research 2007, 7:116 http://www.biomedcentral.com/1472-6963/7/116
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sensitivity to change over time [30,31], and takes minutes
to complete [32]. The SF-36 has been widely used in this
patient population [2].
Secondary measures
HR-QOL will be assessed at six months after ICU dis-
charge. Quality-adjusted life years (QALYs) using EQ-5D
[33]; incidence and severity of posttraumatic psychopa-
thology as measured by Davidson Trauma Scale (DTS);
anxiety and depression using Hospital Anxiety and
Depression Scale (HADS) will be assessed at both six and
twelve months. Contacts with health services measured as
part of the economic analysis; patient satisfaction will be
assessed at twelve months using a patient satisfaction sur-
vey; primary and secondary health care costs in the year
after hospital discharge, and mortality in the twelve
months after ICU discharge. All non-clinic interventions
will be monitored and documented. These data will be
collected from hospital case notes review and patient
questionnaires.
The EQ-5D assesses five attributes of quality of life,
namely mobility, self-care, usual activity, pain/discom-
fort, and anxiety and depression [2]. An overall single
score is obtained which can then be converted into a util-
ity score. The DTS [34] will assess posttraumatic psycho-
pathology and the HADS [35], anxiety and depression.
Both the DTS and HADS have been validated in this
patient population [6,9,16,19]. The DTS has been used
widely in the initial assessment of patients at risk of post-
traumatic stress disorder (PTSD). It measures all core
symptoms of PTSD i.e. intrusion, avoidance and hyperar-
ousal and has a 'cut-off' score of 27 or more that indicates
significant posttraumatic psychopathology whilst a score
of 40 or more indicates a likely diagnosis of PTSD [34].
The HADS questionnaire contains 14 statements and scor-
ing results in scales of 0–21 for anxiety and depression
respectively. Scores of 8–10 indicate the possibility of anx-
iety or depression, and 11 and above indicate that these
are likely to be present.
The Intensive Care Experience Questionnaire (ICE) will
be used to assess patients' perceptions of their experience
[8]. This measure assesses four aspects of such an experi-
ence – 'awareness of surroundings', 'frightening experi-
ences', 'recall of experiences', and 'satisfaction with care'.
Previous work has demonstrated its association with both
short and long-term psychological outcome [8], and we
have used the median value from the 'frightening experi-
ences' aspect as the score for the randomisation proce-
dure.
Intervention Group
These patients will be randomised to the ICU follow up
programme and attend clinic appointments at 2 – 3
months and 9 months after hospital discharge. The design
and timing of these clinics has been determined by the
guidelines on ICU follow up from the Outreach Forum
[11] and by the information collected from our survey of
current practice. Clinics will be primarily nurse-led with
support from an intensive care doctor. This doctor will be
available to consult with the patient (at the nurse's
request) to discuss medical aspects of the patient's origi-
nal ICU stay or ongoing treatment issues relating to ICU
management.
Evidence suggests that a self-directed rehabilitation pro-
gramme may improve outcome after ICU [19]. Therefore
immediately after enrolment patients will be offered a
self-directed rehabilitation programme to follow at home.
This will be individualised to each patient after a discus-
sion between the clinic nurse and a physiotherapist
involved in the patient's hospital care.
Prior to the clinic appointments the ICU follow-up nurse
will review the patient's case notes and clinical audit data-
base to highlight any specific issues which might have
arisen between discharge and the clinic appointment. The
clinic consultation will be structured using a proforma
which has been developed in centres with experience of
following up these patients. Patients and relatives will
have the opportunity to discuss their ICU experiences and
this will be informed by responses to specific items
included in the proforma and also by a free ranging dis-
cussion led by the patients and their families.
Physical recovery will be assessed at the clinic using a
structured questionnaire currently used by one of the
existing centres. This is divided into two sections with one
asking about both general health and specific problems or
changes since being in intensive care. These reflect our cur-
rent understanding of such problems, [4,5] for example
hoarseness, breathlessness, eating difficulties, joint stiff-
ness, parasthesia, concentration and memory difficulties.
Where indicated patients may be referred to specialist
services e.g. physiotherapy. Psychological recovery will be
assessed using the standardised screening measures, and
patients scoring above the 'cut-point' scores will be
referred to a mental health professional (such as a clinical
psychologist, psychiatrist or mental health nurse) for
review.
Current drug therapy will be reviewed. It is common for
drugs started during the ICU stay to be continued unnec-
essarily long after hospital discharge. The clinic nurse will
review current medications and, in liaison with the ICU
doctor, will consider the appropriateness of continuing
these therapies.BMC Health Services Research 2007, 7:116 http://www.biomedcentral.com/1472-6963/7/116
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Patients will be offered an ICU visit if appropriate at an
other time. The presence of altered memories and delu-
sional ideation are related to severe psychological mor-
bidity after ICU discharge. A return visit to ICU will only
be offered if the patient has no psychological problems on
screening (or after assessment by mental health profes-
sional if caseness was established on screening). For cer-
tain patients a visit to the ICU is recognised to help to
develop greater understanding of their memories and
delusions, and may aid recovery.
After each clinic visit, a review letter explaining the
patient's progress will be sent to the general practitioner
(GP). For good clinical practice the patient's GP will be
informed of the patient's status and any referrals required
as a result of the clinic visit. All interventions will use
standard NHS processes, which reflect the pragmatic
nature of this study.
The interventions are clearly specified and, wherever pos-
sible, chosen to replicate the standard processes of the
NHS in the UK to allow the study intervention to be repro-
duced accurately in all study centres. However, to ensure
that trial patients always receive the appropriate trial inter-
ventions we have also organised direct, assured and
named pathways for referral to specialist services.
We have chosen to have three trial centres with one study
nurse carrying out the intervention in each centre. These
nurses will be trained together by nurses who currently
carry out ICU follow up programmes to ensure a high
level of standardisation; their application of the protocol
will be monitored.
Standard care
In line with standard clinical practice in the UK patients
allocated to the standard care group will have no intensive
care follow-up after hospital discharge. Patients will be
followed-up for the trial outcome measures and end
points only over the first year after hospital discharge. In
line with good clinical practice, if there are concerns about
the well being of these patients at trial follow-up, a GP let-
ter will be generated.
Procedure
Trial recruitment and baseline measurements
Patients will be approached in the period after ICU dis-
charge and before hospital discharge, when their condi-
tion has been identified as stable and they are able to give
informed consent. The local trial nurse will explain the
trial and allow time for the patients to read an informa-
tion sheet before seeking written informed consent.
Patients will have baseline measurements recorded before
allocation to their study group. Clinically-gathered data
on patient demographics, ICU diagnosis, ICU stay, sever-
ity of illness using the Acute Physiology, Age and Chronic
Health Evaluation (APACHE II) system [36], APACHE II
co-morbidity score, ICU interventions and sedative use
will be extracted from clinical audit data which is col-
lected routinely during ICU stay in all units and available
at time of enrolment. Also at baseline we will measure SF-
36, EQ-5D, ICE score and HADS score before group allo-
cation.
Allocation of participants to trial groups
After recruitment the patients will be randomised using
the existing central automated computerised telephone
randomisation service within the Centre for Healthcare
Randomised Trials (CHaRT) in the Health Services
Research Unit in the University of Aberdeen. Allocation
will incorporate randomisation at baseline according to
age, sex, HADS score, APACHE II, ICE questionnaire score
and trial centre
Methods for protecting against other sources of bias
Due to the nature of the trial intervention, the nurses and
doctors performing trial intervention cannot be blind to
the trial group allocation. The researchers who measure
trial end points and who will analyse the data will be
blinded to the trial groups. To reduce bias, the principal
outcome measures are questionnaires completed by par-
ticipants at a time equivalent to three months after each
clinic assessment. The analyses will be based on the 'inten-
tion to treat' principle including patients who cannot
attend clinics due to psychiatric treatment.
Frequency and duration of follow up
Patients will be followed-up at six and twelve months for
the patient-assessed measures of outcome. Postal ques-
tionnaires, rather than in-person assessment, have been
chosen to avoid the six months outcome measurement
acting as a trial intervention. This will also help to stand-
ardise the method of data collection.
Sample size
Previous studies performed in Aberdeen have shown a SF-
36 mean physical component score (PCS) of 35 (S.D. 14)
in ICU patients one year after ICU discharge (50 being the
population norm). We have powered this study to detect
a difference of 5 PCS points (0.36 SDs) increase in the
clinic group compared to the standard care group (i.e. 35
to 40). For an unadjusted analysis, 123 patients per group
would be required to detect this difference with 80%
power and α of 0.05. However, data from previous studies
in Aberdeen [2] indicate that the correlation between
baseline, 3 month and 12 month SF-36 scores were at
least 0.6. Such high correlations imply that the sample
size could be reduced by 36% and the study would still
detect a 5-point difference. Taking a more conservative
estimate of 30% reduction in sample size, we would needBMC Health Services Research 2007, 7:116 http://www.biomedcentral.com/1472-6963/7/116
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86 patients per group (172 total) to detect this difference
with an 80% power at an α of 0.05. In practice, the power
should be greater than 80% once the randomisation vari-
ables have been included in the statistical modelling. In
our previous work we have found that 20% of patients
who are discharged alive from hospital are lost to follow
up/do not return questionnaires over the first year [2,6,8].
We will attempt to minimise this form of trial loss by
keeping records of patients' telephone contact details as
well as secondary contact names and addresses. All
patients will be contacted by phone if they fail to return
questionnaires and asked if they want to continue with
the study. Nevertheless, we are assuming a 20% loss to fol-
low-up and 20% mortality at 12 months; thus, the total
number of patients to be recruited will be inflated to 135
per group or 270 in total.
Planned analyses
The outcomes will be compared between groups using
generalised linear models which adjust for the randomisa-
tion factors. The model used will reflect the type of out-
come data. For the primary outcome statistical
significance will be at the 5% level (2P < 0.05) and 95%
confidence intervals will be derived. A priori subgroup
analysis will be undertaken for severity of illness
(APACHE II), APACHE II co-morbidity, ICE score [8] and
ICU length of stay. All subgroup analyses will seek stricter
levels of significance (2P < 0.01). Data will be analysed
using SPSS software.
Economic issues
A formal economic evaluation is an integral part of this
project. Cost per participant for each arm of the trial will
be calculated. An estimate of primary and secondary care
resource utilisation per patient will be made using patient
questionnaires and review of hospital notes over the first
year after hospital discharge. Unit costs/prices will be
obtained using published estimates for health care serv-
ices and/or interventions as well as study specific esti-
mates [37-39]. QALYs will be calculated using the area
under the curve method. For this, EQ-5D questionnaire
responses will be valued using UK population tariffs [33].
The estimation of QALYs will take account of the mortal-
ity of study participants. Participants who die within the
follow-up period will be assigned a zero utility weight
from their death to the end of the follow-up. QALYs
before death will be calculated using linear extrapolation
between QALY scores. Point estimates for mean costs and
mean QALYs will be derived for treatment and control
groups to obtain Incremental Cost per QALY gained.
Measures of variance of outcomes are likely to involve
bootstrapping estimates for costs and QALYs. Results will
be presented using Cost Effectiveness Acceptability Curves
(CEACs). Deterministic and probabilistic sensitivity anal-
ysis will be developed to address different types of uncer-
tainties within the economic evaluation such as
differences in death rate. An element of this sensitivity
analysis will be to explore the impact of extrapolating to a
longer time than that afforded by the trial. This will be
informed by previous research in which we have been
involved [2,6,8], and will use a variety of modelling tech-
niques. Subgroup analysis will follow the subgroup defi-
nitions within the trial.
Conclusion
The provision of intensive care follow-up clinics within
the UK has developed in an ad hoc manner, is inconsist-
ent in both the number of hospitals offering such a service
or in the type of service offered. This study provides the
opportunity to evaluate such services both in terms of
patient benefit and cost-effectiveness. The results of this
study therefore will inform clinical practice and policy
with regard to the appropriate development of such serv-
ices aimed at improving outcomes after intensive care.
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